Metropolitan Life Insurance Company (MetLife)’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,137
| Closed | -$89.1K | – | 633 |
|
|
2024
Q1 | $89.1K | Buy |
3,137
+761
| +32% | +$21.6K | ﹤0.01% | 1109 |
|
|
2023
Q4 | $31.6K | Hold |
2,376
| – | – | ﹤0.01% | 1687 |
|
|
2023
Q3 | $21.3K | Hold |
2,376
| – | – | ﹤0.01% | 1862 |
|
|
2023
Q2 | $26.7K | Buy |
2,376
+326
| +16% | +$3.67K | ﹤0.01% | 1776 |
|
|
2023
Q1 | $23.6K | Hold |
2,050
| – | – | ﹤0.01% | 1793 |
|
|
2022
Q4 | $23.8K | Sell |
2,050
-532
| -21% | -$6.17K | ﹤0.01% | 1916 |
|
|
2022
Q3 | $32.8K | Hold |
2,582
| – | – | ﹤0.01% | 1741 |
|
|
2022
Q2 | $17.7K | Hold |
2,582
| – | – | ﹤0.01% | 2098 |
|
|
2022
Q1 | $24.9K | Sell |
2,582
-7,180
| -74% | -$69.2K | ﹤0.01% | 1991 |
|
|
2021
Q4 | $116K | Buy |
9,762
+2,725
| +39% | +$32.4K | ﹤0.01% | 2384 |
|
|
2021
Q3 | $114K | Sell |
7,037
-2,180
| -24% | -$35.4K | ﹤0.01% | 2452 |
|
|
2021
Q2 | $194K | Buy |
+9,217
| New | +$194K | ﹤0.01% | 2162 |
|
|
2021
Q1 | – | Sell |
-5,226
| Closed | -$110K | – | 2591 |
|
|
2020
Q4 | $110K | Buy |
+5,226
| New | +$110K | ﹤0.01% | 2312 |
|